Omega-3 polyunsaturated fatty acid supplementation in prevention and treatment of maternal depression: Putative mechanism and recommendation - PubMed (original) (raw)
Review
Omega-3 polyunsaturated fatty acid supplementation in prevention and treatment of maternal depression: Putative mechanism and recommendation
Mei-Chi Hsu et al. J Affect Disord. 2018.
Abstract
Background: Women are vulnerable to depression during their childbearing years, and giving birth to a child precipitates postpartum depression (PPD) in some women. This review focuses on comparing the effectiveness of omega-3 polyunsaturated fatty acid supplementation on depression during pregnancy or PPD after childbirth.
Methods: MEDLINE, PubMed, PsycINFO, and the Cochrane Collaboration Registry of Controlled Trials etc. through July 2017 were searched. Studies of dietary intake and plasma and/or milk levels of omega-3 fatty acids and trials of benefits and effects of omega-3 fatty acids supplements on pregnant or postpartum women with depression were specifically selected.
Results: Omega-3 fatty acid deficiency, due to inadequate intake, fast depletion during pregnancy and lactation, is one of the risk factors of PPD. Associations between neuroinflammation (elevated pro-inflammatory cytokines) and aberrant neurotransmission (low serotonergic transmission activity) and risk of PPD have also been reported by numerous studies. Supplementation with eicosapentaenoic acid (EPA)-rich oil can effectively reduce depression during pregnancy and PPD after childbirth. Long term treatment with docosahexaenoic acid (DHA)-rich oil can be effective in reducing the risk of PPD in healthy women, but not in lactating women. Supplementation of DHA-rich oil to women begun at pregnancy and continued after childbirth exerts no beneficial effect on depression.
Conclusions: Dietary supplementation with omega-3 fatty acids rich in EPA during pregnancy or postpartum reduces some symptoms associated with depression. DHA supplementation to healthy pregnant women can also reduce the risk of PPD.
Keywords: Caring; Gonadal hormones; Neurotransmission; Nutrition; Omega-3 fatty acids; Postpartum depression.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
- Dietary supplements for preventing postnatal depression.
Miller BJ, Murray L, Beckmann MM, Kent T, Macfarlane B. Miller BJ, et al. Cochrane Database Syst Rev. 2013 Oct 24;2013(10):CD009104. doi: 10.1002/14651858.CD009104.pub2. Cochrane Database Syst Rev. 2013. PMID: 24158923 Free PMC article. Review. - The mothers, Omega-3 and mental health study.
Mozurkewich E, Chilimigras J, Klemens C, Keeton K, Allbaugh L, Hamilton S, Berman D, Vazquez D, Marcus S, Djuric Z, Vahratian A. Mozurkewich E, et al. BMC Pregnancy Childbirth. 2011 Jun 22;11:46. doi: 10.1186/1471-2393-11-46. BMC Pregnancy Childbirth. 2011. PMID: 21696635 Free PMC article. Clinical Trial. - Omega-3 supplementation from pregnancy to postpartum to prevent depressive symptoms: a randomized placebo-controlled trial.
Vaz JDS, Farias DR, Adegboye ARA, Nardi AE, Kac G. Vaz JDS, et al. BMC Pregnancy Childbirth. 2017 Jun 9;17(1):180. doi: 10.1186/s12884-017-1365-x. BMC Pregnancy Childbirth. 2017. PMID: 28599630 Free PMC article. Clinical Trial. - Allergic disease in infants up to 2 years of age in relation to plasma omega-3 fatty acids and maternal fish oil supplementation in pregnancy and lactation.
Furuhjelm C, Warstedt K, Fagerås M, Fälth-Magnusson K, Larsson J, Fredriksson M, Duchén K. Furuhjelm C, et al. Pediatr Allergy Immunol. 2011 Aug;22(5):505-14. doi: 10.1111/j.1399-3038.2010.01096.x. Epub 2011 Feb 20. Pediatr Allergy Immunol. 2011. PMID: 21332799 Clinical Trial. - Maternal omega-3 fatty acid supplementation and risk for perinatal maternal depression.
Wojcicki JM, Heyman MB. Wojcicki JM, et al. J Matern Fetal Neonatal Med. 2011 May;24(5):680-6. doi: 10.3109/14767058.2010.521873. Epub 2010 Oct 7. J Matern Fetal Neonatal Med. 2011. PMID: 20925595 Free PMC article. Review.
Cited by
- Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders.
Gupta R, Advani D, Yadav D, Ambasta RK, Kumar P. Gupta R, et al. Mol Neurobiol. 2023 Nov;60(11):6476-6529. doi: 10.1007/s12035-023-03502-9. Epub 2023 Jul 17. Mol Neurobiol. 2023. PMID: 37458987 Review. - Safety and efficacy of supplements in pregnancy.
Brown B, Wright C. Brown B, et al. Nutr Rev. 2020 Oct 1;78(10):813-826. doi: 10.1093/nutrit/nuz101. Nutr Rev. 2020. PMID: 31925443 Free PMC article. Review. - Carveol Promotes Nrf2 Contribution in Depressive Disorders through an Anti-inflammatory Mechanism.
Muhammad AJ, Hao L, Al Kury LT, Rehman NU, Alvi AM, Badshah H, Ullah I, Shah FA, Li S. Muhammad AJ, et al. Oxid Med Cell Longev. 2022 Mar 7;2022:4509204. doi: 10.1155/2022/4509204. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35295720 Free PMC article. Retracted. - Levels of _n_-3 and _n_-6 Fatty Acids in Maternal Erythrocytes during Pregnancy and in Human Milk and Its Association with Perinatal Mental Health.
Urech C, Eussen SRBM, Alder J, Stahl B, Boehm G, Bitzer J, Bartke N, Hoesli I. Urech C, et al. Nutrients. 2020 Sep 11;12(9):2773. doi: 10.3390/nu12092773. Nutrients. 2020. PMID: 32932815 Free PMC article. - Metabolomic Investigation of Major Depressive Disorder Identifies a Potentially Causal Association With Polyunsaturated Fatty Acids.
Davyson E, Shen X, Gadd DA, Bernabeu E, Hillary RF, McCartney DL, Adams M, Marioni R, McIntosh AM. Davyson E, et al. Biol Psychiatry. 2023 Oct 15;94(8):630-639. doi: 10.1016/j.biopsych.2023.01.027. Epub 2023 Feb 9. Biol Psychiatry. 2023. PMID: 36764567 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials